May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA Leendert van den BosChief Executive Officer at EnzyTag BVSpeaker
Profile
Leendert van den Bos obtained his MSc- and PhD-degree in bio-organic chemistry from Leiden University. He joined Organon BioSciences as a Scientist in 2007 and worked subsequently for Schering-Plough, Merck Sharp & Dohme and Aspen Pharmacare mostly in the field of Process Research & Development. In 2019 he co-founded EnzyTag and served as CEO ever since. Leendert holds an Executive MBA from Nyenrode University. |
Agenda Sessions
Fragment-Based Approaches for the Production of Peptide-based Therapeutics for Diabetes and Obesity
, 3:00pmView Session